1st Edition
Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders
1. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Type 2 Diabetes
Baharudin Ibrahim, Abubakar Sha’aban, and Kayatri Govindaraju
2. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Thyroid Disorders
Yaser Mohammed Al-Worafi
3. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Asthma
Yaser Mohammed Al-Worafi, Wafa Alsaeedi, and Long Chiau Ming
4. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Rhinitis
Yaser Mohammed Al-Worafi
5. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Cystic Fibrosis Management
Deepa Shakya, Sweta Shrestha, Asmita Priyadarshini Khatiwada, Nita Shrestha, Rajeev Shrestha, Binaya Sapkota, and Nabin Pathak
6. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Acute Kidney Disease
Yaser Mohammed Al-Worafi
7. Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Glomerulonephritis
Yaser Mohammed Al-Worafi
8.Evidence-Based Pharmacist Care (Clinical, Economic, andHumanistic Impact): Renal Dialysis
Yaser Mohammed Al-Worafi
Biography
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patients care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.
